Logo image of LFMDP

LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis

NASDAQ:LFMDP - Nasdaq - US53216B2034 - Currency: USD

22.315  -0.58 (-2.55%)

Fundamental Rating

3

Taking everything into account, LFMDP scores 3 out of 10 in our fundamental rating. LFMDP was compared to 39 industry peers in the Health Care Technology industry. LFMDP has a bad profitability rating. Also its financial health evaluation is rather negative. LFMDP shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LFMDP has reported negative net income.
In the past year LFMDP had a positive cash flow from operations.
In the past 5 years LFMDP always reported negative net income.
In multiple years LFMDP reported negative operating cash flow during the last 5 years.
LFMDP Yearly Net Income VS EBIT VS OCF VS FCFLFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of LFMDP (-35.30%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -35.3%
ROE N/A
ROIC N/A
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMDP Yearly ROA, ROE, ROICLFMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5K -10K -15K

1.3 Margins

LFMDP's Gross Margin of 89.64% is amongst the best of the industry. LFMDP outperforms 91.89% of its industry peers.
LFMDP's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LFMDP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
LFMDP Yearly Profit, Operating, Gross MarginsLFMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMDP has more shares outstanding
Compared to 5 years ago, LFMDP has more shares outstanding
LFMDP has a worse debt/assets ratio than last year.
LFMDP Yearly Shares OutstandingLFMDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
LFMDP Yearly Total Debt VS Total AssetsLFMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 4.48 indicates that LFMDP is not in any danger for bankruptcy at the moment.
LFMDP's Altman-Z score of 4.48 is fine compared to the rest of the industry. LFMDP outperforms 75.68% of its industry peers.
LFMDP has a debt to FCF ratio of 1.72. This is a very positive value and a sign of high solvency as it would only need 1.72 years to pay back of all of its debts.
The Debt to FCF ratio of LFMDP (1.72) is better than 72.97% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.72
Altman-Z 4.48
ROIC/WACCN/A
WACC10.37%
LFMDP Yearly LT Debt VS Equity VS FCFLFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

LFMDP has a Current Ratio of 0.83. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMDP's Current ratio of 0.83 is on the low side compared to the rest of the industry. LFMDP is outperformed by 78.38% of its industry peers.
LFMDP has a Quick Ratio of 0.83. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMDP has a worse Quick ratio (0.78) than 78.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.78
LFMDP Yearly Current Assets VS Current LiabilitesLFMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.69% over the past year.
LFMDP shows a strong growth in Revenue. In the last year, the Revenue has grown by 42.15%.
LFMDP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.00% yearly.
EPS 1Y (TTM)34.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)42.15%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Sales Q2Q%38.28%

3.2 Future

LFMDP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.61% yearly.
Based on estimates for the next years, LFMDP will show a very strong growth in Revenue. The Revenue will grow by 28.23% on average per year.
EPS Next Y19.44%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
EPS Next 5Y32.61%
Revenue Next Year38.86%
Revenue Next 2Y31.79%
Revenue Next 3Y26.74%
Revenue Next 5Y28.23%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFMDP Yearly Revenue VS EstimatesLFMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
LFMDP Yearly EPS VS EstimatesLFMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

1

4. Valuation

4.1 Price/Earnings Ratio

LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFMDP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFMDP Price Earnings VS Forward Price EarningsLFMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as LFMDP.
Industry RankSector Rank
P/FCF 90.93
EV/EBITDA N/A
LFMDP Per share dataLFMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as LFMDP's earnings are expected to grow with 31.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.7%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.95%, LFMDP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 52.78, LFMDP pays a better dividend. On top of this LFMDP pays more dividend than 97.30% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.29, LFMDP pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.95%

5.2 History

LFMDP has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
LFMDP Yearly Dividends per shareLFMDP Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-12.13%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
LFMDP Yearly Income VS Free CF VS DividendLFMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

LIFEMD INC - LFMD 8 7/8 PERP

NASDAQ:LFMDP (2/21/2025, 8:00:02 PM)

22.315

-0.58 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-10 2025-03-10/amc
Inst Owners38.56%
Inst Owner ChangeN/A
Ins Owners17.06%
Ins Owner ChangeN/A
Market Cap966.46M
Analysts81.33
Price Target51.89 (132.53%)
Short Float %0%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield 9.95%
Yearly Dividend0.09
Dividend Growth(5Y)N/A
DP-12.13%
Div Incr Years0
Div Non Decr Years1
Ex-Date01-03 2025-01-03 (0.5546875)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.34%
Min EPS beat(2)-49.02%
Max EPS beat(2)-15.66%
EPS beat(4)1
Avg EPS beat(4)-17.42%
Min EPS beat(4)-49.02%
Max EPS beat(4)15.97%
EPS beat(8)2
Avg EPS beat(8)-40.52%
EPS beat(12)3
Avg EPS beat(12)-33.85%
EPS beat(16)5
Avg EPS beat(16)-81.42%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.71%
Max Revenue beat(2)2.94%
Revenue beat(4)3
Avg Revenue beat(4)2.65%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)8.61%
Revenue beat(8)5
Avg Revenue beat(8)-0.32%
Revenue beat(12)5
Avg Revenue beat(12)-2.02%
Revenue beat(16)5
Avg Revenue beat(16)-2.35%
PT rev (1m)-3.97%
PT rev (3m)-14.88%
EPS NQ rev (1m)-16.89%
EPS NQ rev (3m)-15.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.31%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.01
P/FCF 90.93
P/OCF 44.63
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.25
FCFY1.1%
OCF(TTM)0.5
OCFY2.24%
SpS4.46
BVpS-0.18
TBVpS-0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.3%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.64%
FCFM 5.51%
ROA(3y)-117.88%
ROA(5y)-183.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.79%
GM growth 5Y2.59%
F-Score6
Asset Turnover2.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 1.72
Debt/EBITDA N/A
Cap/Depr 124.1%
Cap/Sales 5.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.78
Altman-Z 4.48
F-Score6
WACC10.37%
ROIC/WACCN/A
Cap/Depr(3y)251.46%
Cap/Depr(5y)170.88%
Cap/Sales(3y)5.58%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y19.44%
EPS Next 2Y39.35%
EPS Next 3Y31.7%
EPS Next 5Y32.61%
Revenue 1Y (TTM)42.15%
Revenue growth 3Y59.92%
Revenue growth 5Y79%
Sales Q2Q%38.28%
Revenue Next Year38.86%
Revenue Next 2Y31.79%
Revenue Next 3Y26.74%
Revenue Next 5Y28.23%
EBIT growth 1Y-37.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year187.06%
EBIT Next 3Y67.15%
EBIT Next 5Y59.57%
FCF growth 1Y129.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.8%
OCF growth 3YN/A
OCF growth 5YN/A